PRESENT-DAY advances in psychotherapy have added impetus to investigations into the actions of drugs which affect the central nervous system and thus cause changes in behaviour patterns. One such ...

THE marked aberrations in mental functions produced by minute doses of lysergic acid diethylamide (LSD-25) resemble aspects peculiar to schizophrenia 1,2. As a result the drug has been suggested to be ...

Malformations of the brain, spinal cord, liver, and other viscera; body edema; and localized hemorrhages were found in fetal hamsters from mothers injected subcutaneously with a single dose of ...

This is a preview. Log in through your library . Abstract RNA synthesis in isolated brain nuclei was analyzed 2.5 hr after the intravenous administration of d-lysergic acid diethylamide (LSD) to young ...

— Study Published in Psychopharmacology and Presented at the 12 th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD —Scientific ...

NO drug used by man has stimulated greater public-debate than lysergic acid diethylamide (LSD). This brief review of the current status of the drug will summarize its pharmacology, medical uses and ...

Drugs targeting receptors of the neurotransmitter serotonin (5-hydroxytryptamine [5-HT]) are widely used in neuropsychiatry and some such agents, most notably psilocybin, have shown potential for ...

Albert Hofmann, the Swiss chemist who discovered LSD and thereby gave the psychedelic generation the pharmaceutical vehicle to turn on, tune in and drop out, has died. He was 102. Hofmann died Tuesday ...

Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates US$50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...